Anti-Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma.
about
Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cellsImmunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinomaCell-cell interaction in prostate gene regulation and cytodifferentiation.CD57 expression in incidental, clinically manifest, and metastatic carcinoma of the prostate.Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with rectal cancer.
P2860
Anti-Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@ast
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@en
type
label
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@ast
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@en
prefLabel
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@ast
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@en
P2860
P1433
P1476
Anti-Leu 7 immunoreactivity wi ...... s of prostatic adenocarcinoma.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.1987.TB02634.X
P577
1987-03-01T00:00:00Z